[go: up one dir, main page]

WO2009109990A3 - Composition pharmaceutique de pramipexole - Google Patents

Composition pharmaceutique de pramipexole Download PDF

Info

Publication number
WO2009109990A3
WO2009109990A3 PCT/IN2009/000056 IN2009000056W WO2009109990A3 WO 2009109990 A3 WO2009109990 A3 WO 2009109990A3 IN 2009000056 W IN2009000056 W IN 2009000056W WO 2009109990 A3 WO2009109990 A3 WO 2009109990A3
Authority
WO
WIPO (PCT)
Prior art keywords
sugar alcohol
pramipexole
composition
pharmaceutically acceptable
pramipexole composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2009/000056
Other languages
English (en)
Other versions
WO2009109990A2 (fr
Inventor
Vaishali Vijay Dhavse
Nitin Bhalachandra Dharmadhikari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Ltd
Original Assignee
Sun Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Ltd filed Critical Sun Pharmaceutical Industries Ltd
Publication of WO2009109990A2 publication Critical patent/WO2009109990A2/fr
Publication of WO2009109990A3 publication Critical patent/WO2009109990A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L’invention concerne une composition pharmaceutique comportant du pramipexole ou ses sels pharmaceutiquement acceptables ou ses hydrates ou les solvats de ce composé, un (des) alcool(s) de sucre et un milieu véhicule pharmaceutiquement acceptable ne contenant pratiquement pas de pyrrolidone de polyvinyle.
PCT/IN2009/000056 2008-01-24 2009-01-22 Composition pharmaceutique de pramipexole Ceased WO2009109990A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN176/MUM/2008 2008-01-24
IN176MU2008 2008-01-24

Publications (2)

Publication Number Publication Date
WO2009109990A2 WO2009109990A2 (fr) 2009-09-11
WO2009109990A3 true WO2009109990A3 (fr) 2009-12-10

Family

ID=41056430

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000056 Ceased WO2009109990A2 (fr) 2008-01-24 2009-01-22 Composition pharmaceutique de pramipexole

Country Status (1)

Country Link
WO (1) WO2009109990A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772403B (zh) * 2011-05-10 2015-11-25 浙江京新药业股份有限公司 普拉克索制剂及其制备方法
KR20250108755A (ko) * 2017-03-27 2025-07-15 체이스 테라퓨틱스 코포레이션 시누클레인병변을 치료하기 위한 조성물 및 방법
WO2019010146A1 (fr) * 2017-07-03 2019-01-10 Chase Therapeutics Corporation Compositions à base de statine et procédés destinés à être utilisés dans le traitement de synucléinopathies

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004100857A2 (fr) * 2003-05-07 2004-11-25 Akina, Inc. Granules a teneur elevee en plastique, destines a la fabrication de comprimes a dissolution rapide
US20070148238A1 (en) * 2005-06-23 2007-06-28 Spherics, Inc. Dosage forms for movement disorder treatment
US20070196494A1 (en) * 2006-02-17 2007-08-23 Arnaud Grenier Low-friability, patient-friendly orally disintegrating formulations
US20080014259A1 (en) * 2006-05-16 2008-01-17 Knopp Neurosciences, Inc. Compositions of R(+) and S(-) Pramipexole and Methods of Using the Same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004100857A2 (fr) * 2003-05-07 2004-11-25 Akina, Inc. Granules a teneur elevee en plastique, destines a la fabrication de comprimes a dissolution rapide
US20070148238A1 (en) * 2005-06-23 2007-06-28 Spherics, Inc. Dosage forms for movement disorder treatment
US20070196494A1 (en) * 2006-02-17 2007-08-23 Arnaud Grenier Low-friability, patient-friendly orally disintegrating formulations
US20080014259A1 (en) * 2006-05-16 2008-01-17 Knopp Neurosciences, Inc. Compositions of R(+) and S(-) Pramipexole and Methods of Using the Same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE HCAPLUS [online] Database accession no. 2008:927685 *
DATABASE WPI Derwent World Patents Index; AN 2008-L38683 *

Also Published As

Publication number Publication date
WO2009109990A2 (fr) 2009-09-11

Similar Documents

Publication Publication Date Title
PL2049557T3 (pl) Pochodne 1-(d-glikopiranozylo)-3-(4-cyklopropylofenylometylo)-4-fluorowcoindolu i ich zastosowanie jako inhibitorów sglt
GEP20125410B (en) Solid preparation comprising alogliptin and pioglitazone
WO2011051971A3 (fr) Dispersion solide de rifaximine
HUS1400056I1 (hu) Glükopiranozil-helyettesített benzol-származékok, az említett vegyületeket tartalmazó gyógyszerek, azok alkalmazása, és eljárás elõállításukra
WO2007121318A3 (fr) Préparations destinées à l'administration d'insuline
WO2007125547A3 (fr) Nouveau procédé faisant intervenir des statines et leurs sels acceptables sur le plan pharmaceutique
WO2008053232A3 (fr) Composition de réduction de la mycotoxine
WO2009042114A3 (fr) Dérivés de phénazine et leurs utilisations
AU2007329728A1 (en) 3-(dihydro-1H-pyrazolo (4,3-d) pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
AU2008246443A8 (en) 1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase
WO2007144169A3 (fr) Dérivés d'entacapone
SI2448927T1 (sl) Novi (6-okso-1,6-dihidro-pirimidin-2-il)-amidni derivati, njihova priprava in njihova farmacevtska uporaba kot AKT fosforilacijski inhibitorji
WO2007099171A3 (fr) Bicyclopyrazoles actifs comme inhibiteurs de la kinase
WO2005118831A3 (fr) Compositions poylmeres et procedes associes d'utilisation
WO2006067392A3 (fr) Composes
WO2009149058A8 (fr) Formulations de niacine à libération modifiée
EP2121601B8 (fr) Nouveaux derives indoliques, leurs procedes de preparation et leurs utilisations notamment en tant qu'antibacteriens
WO2009109990A3 (fr) Composition pharmaceutique de pramipexole
WO2010148314A3 (fr) Préparation d'ésoméprazole et de ses sels pharmaceutiquement acceptables
WO2007099555A3 (fr) Compositions pharmaceutiques contenant de l'irbésartan
WO2007062314A3 (fr) Inhibiteurs de cetp heterocycliques
WO2009007747A3 (fr) Nouveaux composés
WO2010023693A3 (fr) Nouvelles compositions de ropinirole à libération contrôlée
GB0606392D0 (en) Culture medium containing kinase inhibitors, and uses thereof
WO2009047800A3 (fr) Composition orale à libération contrôlée de carvédilol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09717908

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09717908

Country of ref document: EP

Kind code of ref document: A2